Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Simonds EF, Lu ED, Badillo O, Karimi S, Liu EV, Tamaki W, Rancan C, Downey KM, Stultz J, Sinha M, McHenry LK, Nasholm NM, Chuntova P, Sundström A, Genoud V, Shahani SA, Wang LD, Brown CE, Walker PR, Swartling FJ, Fong L, Okada H, Weiss WA, Hellström M.
Simonds EF, et al. Among authors: lu ed.
J Immunother Cancer. 2021 Jun;9(6):e002181. doi: 10.1136/jitc-2020-002181.
J Immunother Cancer. 2021.
PMID: 34083417
Free PMC article.